AGP Picks
View all

Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

Press releases published on August 4, 2026

Luxury Rail Safaris Launches US Website for Rovos Rail With Dollar Pricing
ROJAN FRAGRANCE TRADING (PTY) LTD Launches Phase Two of Its South Africa Expansion Strategy
AfriVest and the Traditional Leaders of Southern Africa Sign Master Tokenization Partnership Agreement
LIFT Announces C$20 Million Public Offering
Swaziland Building Society goes live with eMACH.ai Treasury, powering their strategic transition to commercial banking
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
ROJAN FRAGRANCE TRADING (PTY) LTD Launches Phase Two of South Africa Expansion Strategy
Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th
Northern Discovery Metals Highlights Multiple Copper Targets Identified in NI 43-101 Technical Report for Vent
GoldInxs to Commence 3D Induced Polarization (IP) Survey at Fishpot Property
FDA clears Healis Therapeutics’ IND for Tyemvers®, Enabling U.S. Neuropsychiatric Trials
Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa Daily Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.